Mumbai-based pharmaceutical company Lupin Limited has received U.S. FDA approval for Ranluspec biosimilar (ranibizumab-hkdz), a biosimilar to Lucentis used in the treatment of serious eye conditions. The approval marks an important step in Lupin...
Cancer treatment in India is facing fresh challenges as hospitals across the country report shortages of key chemotherapy drugs, raising concerns among doctors and patients. The shortage of essential medicines such as Cisplatin and Carboplat...
TheraNym Biologics, a contract manufacturing arm of Aurobindo Pharma, has inaugurated a state-of-the-art biologics manufacturing facility in Telangana with an investment of ?1,200 crore, marking a significant expansion in India’s advanced pharma...
Moderna and the Coalition for Epidemic Preparedness Innovations (CEPI) have joined forces to accelerate the development of a vaccine for the Bundibugyo strain of Ebola, marking a major step in global efforts to strengthen outbreak preparedness.
Novo Nordisk’s Wegovy has received approval in India for teenagers struggling with obesity, opening a new treatment option for young patients aged 12 years and above. The approval of Novo Nordisk’s Wegovy in India for teens battling obesity come...
AI-generated fake prescriptions fueling misuse of antibiotics and psychotropic drugs are becoming a growing concern in India, raising serious questions about patient safety and online medicine sales. Health experts and chemists warn that fak...
Tata-backed MedTherapy claims a CAR-T breakthrough, marking what could be a major shift in cancer treatment manufacturing. The company says it can now produce CAR-T therapy within just 24 hours, compared to the several weeks the process usual...
Tata Elxsi has launched ViTel, an AI-driven material intelligence solution for medical device manufacturers, co-developed with Viridium AI. The new platform, formally introduced today at DeviceTalks Boston 2026, aims to help MedTech companie...
.jpeg)
Moderna and Merck melanoma combo cuts spread risk by 59% in 5-year study. Personalized cancer vaccine with Keytruda shows strong survival gains and recurrence prevention.
India emerges as Novo Nordisk’s global launch engine, powering AI-led drug development, faster approvals, and stronger Wegovy data amid rising competition in obesity drugs.
.jpg)
, CDSCO.jpg)